Table of Contents
1. Methodology and Scope
1.1. Methodology
1.1.1. Initial data exploration
1.1.2. Statistical model and forecast
1.1.3. Industry insights and validation
1.1.4. Definitions forecast parameters
1.2. Data sources
1.2.1. Secondary
1.2.2. Primary
2 Market Overview
2.1 Induced Pluripotent Stem Cells (iPSCs) Introduction
2.2 Market Analysis by Type
2.2.1 Human iPSCs
2.2.2 Mouse iPSCs
2.3 Market Analysis by Applications
2.3.1 Academic Research
2.3.2 Drug Development and Discovery
2.3.3 Toxicity Screening
2.3.4 Regenerative Medicine
2.4 Market Analysis by Regions
2.4.1 North America (United States, Canada and Mexico)
2.4.1.1 United States Market Status and Outlook (2013-2026)
2.4.1.2 Canada Market Status and Outlook (2013-2026)
2.4.1.3 Mexico Market Status and Outlook (2013-2026)
2.4.2 Europe (Germany, France, UK, Russia and Italy)
2.4.2.1 Germany Market Status and Outlook (2013-2026)
2.4.2.2 France Market Status and Outlook (2013-2026)
2.4.2.3 UK Market Status and Outlook (2013-2026)
2.4.2.4 Russia Market Status and Outlook (2013-2026)
2.4.2.5 Italy Market Status and Outlook (2013-2026)
2.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
2.4.3.1 China Market Status and Outlook (2013-2026)
2.4.3.2 Japan Market Status and Outlook (2013-2026)
2.4.3.3 Korea Market Status and Outlook (2013-2026)
2.4.3.4 India Market Status and Outlook (2013-2026)
2.4.3.5 Southeast Asia Market Status and Outlook (2013-2026)
2.4.4 South America, Middle East and Africa
2.4.4.1 Brazil Market Status and Outlook (2013-2026)
2.4.4.2 Egypt Market Status and Outlook (2013-2026)
2.4.4.3 Saudi Arabia Market Status and Outlook (2013-2026)
2.4.4.4 South Africa Market Status and Outlook (2013-2026)
2.4.4.5 Nigeria Market Status and Outlook (2013-2026)
2.5 Market Dynamics
2.5.1 Market Opportunities
2.5.2 Market Risk
2.5.3 Market Driving Force
2.6 Market Competition News and Trend
2.6.1 Merger, Consolidation or Acquisition News
2.6.2 Investment or Disinvestment News
2.6.3 New Product Development and Launch
3 Global Induced Pluripotent Stem Cells (iPSCs) Sales, Revenue, Market Share and Competition by Manufacturer (2016-2018)
3.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales and Market Share by Manufacturer (2016-2018)
3.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue and Market Share by Manufacturer (2016-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Induced Pluripotent Stem Cells (iPSCs) Manufacturer Market Share
3.3.2 Top 6 Induced Pluripotent Stem Cells (iPSCs) Manufacturer Market Share
3.4 Market Competition Trend
4 Manufacturers Profiles
4.1 Fujifilm Holding Corporation (CDI)
4.1.1 Business Overview
4.1.2 Induced Pluripotent Stem Cells (iPSCs) Type and Applications
4.1.2.1 Product A
4.1.2.2 Product B
4.1.3 Induced Pluripotent Stem Cells (iPSCs) Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.2 ReproCELL
4.2.1 Business Overview
4.2.2 Induced Pluripotent Stem Cells (iPSCs) Type and Applications
4.2.2.1 Product A
4.2.2.2 Product B
4.2.3 Induced Pluripotent Stem Cells (iPSCs) Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.3 Astellas Pharma Inc
4.3.1 Business Overview
4.3.2 Induced Pluripotent Stem Cells (iPSCs) Type and Applications
4.3.2.1 Product A
4.3.2.2 Product B
4.3.3 Induced Pluripotent Stem Cells (iPSCs) Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.4 Ncardia
4.4.1 Business Overview
4.4.2 Induced Pluripotent Stem Cells (iPSCs) Type and Applications
4.4.2.1 Product A
4.4.2.2 Product B
4.4.3 Induced Pluripotent Stem Cells (iPSCs) Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.5 Cell Inspire Biotechnology
4.5.1 Business Overview
4.5.2 Induced Pluripotent Stem Cells (iPSCs) Type and Applications
4.5.2.1 Product A
4.5.2.2 Product B
4.5.3 Induced Pluripotent Stem Cells (iPSCs) Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.6 Sumitomo Dainippon Pharma
4.6.1 Business Overview
4.6.2 Induced Pluripotent Stem Cells (iPSCs) Type and Applications
4.6.2.1 Product A
4.6.2.2 Product B
4.6.3 Sumitomo Dainippon Pharma Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.7 Pluricell Biotech
4.7.1 Business Overview
4.7.2 Induced Pluripotent Stem Cells (iPSCs) Type and Applications
4.7.2.1 Product A
4.7.2.2 Product B
4.7.3 Pluricell Biotech Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
4.8 Fate Therapeutics, Inc
4.8.1 Business Overview
4.8.2 Induced Pluripotent Stem Cells (iPSCs) Type and Applications
4.8.2.1 Product A
4.8.2.2 Product B
4.8.3 Fate Therapeutics, Inc Product Name Sales, Price, Revenue, Gross Margin and Market Share (2016-2018)
5 Global Induced Pluripotent Stem Cells (iPSCs) Market Analysis by Regions
5.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales, Revenue and Market Share by Regions
5.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales and Market Share by Regions (2013-2018)
5.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue and Market Share by Regions (2013-2018)
5.2 North America Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
5.3 Europe Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
5.4 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
5.5 South America Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
5.6 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
6 North America Induced Pluripotent Stem Cells (iPSCs) by Countries
6.1 North America Induced Pluripotent Stem Cells (iPSCs) Sales, Revenue and Market Share by Countries
6.1.1 North America Induced Pluripotent Stem Cells (iPSCs) Sales and Market Share by Countries (2013-2018)
6.1.2 North America Induced Pluripotent Stem Cells (iPSCs) Revenue and Market Share by Countries (2013-2018)
6.2 United States Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
6.3 Canada Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
6.4 Mexico Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
7 Europe Induced Pluripotent Stem Cells (iPSCs) by Countries
7.1 Europe Induced Pluripotent Stem Cells (iPSCs) Sales, Revenue and Market Share by Countries
7.1.1 Europe Induced Pluripotent Stem Cells (iPSCs) Sales and Market Share by Countries (2013-2018)
7.1.2 Europe Induced Pluripotent Stem Cells (iPSCs) Revenue and Market Share by Countries (2013-2018)
7.2 Germany Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
7.3 UK Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
7.4 France Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
7.5 Russia Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
7.6 Italy Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
8 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) by Countries
8.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Sales and Market Share by Countries (2013-2018)
8.1.2 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Revenue and Market Share by Countries (2013-2018)
8.2 China Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
8.3 Japan Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
8.4 Korea Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
8.5 India Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
8.6 Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
9 South America Induced Pluripotent Stem Cells (iPSCs) by Countries
9.1 South America Induced Pluripotent Stem Cells (iPSCs) Sales, Revenue and Market Share by Countries
9.1.1 South America Induced Pluripotent Stem Cells (iPSCs) Sales and Market Share by Countries (2013-2018)
9.1.2 South America Induced Pluripotent Stem Cells (iPSCs) Revenue and Market Share by Countries (2013-2018)
9.2 Brazil Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
9.3 Argentina Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
9.4 Colombia Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
10 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) by Countries
10.1 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Sales and Market Share by Countries (2013-2018)
10.1.2 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Revenue and Market Share by Countries (2013-2018)
10.2 Saudi Arabia Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
10.3 UAE Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
10.4 Egypt Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
10.5 Nigeria Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
10.6 South Africa Induced Pluripotent Stem Cells (iPSCs) Sales and Growth Rate (2013-2018)
11 Global Induced Pluripotent Stem Cells (iPSCs) Market Segment by Type
11.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales, Revenue and Market Share by Type (2013-2018)
11.1.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales and Market Share by Type (2013-2018)
11.1.2 Global Induced Pluripotent Stem Cells (iPSCs) Revenue and Market Share by Type (2013-2018)
11.2 Human iPSCs Sales Growth Rate and Price
11.2.1 Global Human iPSCs Sales Growth Rate (2013-2018)
11.2.2 Global Human iPSCsPrice (2013-2018)
11.3 Mouse iPSCs Sales Growth Rate and Price
11.3.1 Global Mouse iPSCs Sales Growth Rate (2013-2018)
11.3.2 Global Mouse iPSCs Price (2013-2018)
12 Global Induced Pluripotent Stem Cells (iPSCs) Market Segment by Application
12.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Application (2013-2018)
12.2 Academic Research Sales Growth Rate (2013-2018)
12.3 Drug Development and Discovery Sales Growth Rate (2013-2018)
12.4 Toxicity Screening Sales Growth Rate (2013-2018)
12.5 Regenerative Medicine Sales Growth Rate (2013-2018)
13 Induced Pluripotent Stem Cells (iPSCs) Market Forecast (2019-2026)
13.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales, Revenue and Growth Rate (2019-2026)
13.2 Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Regions (2019-2026)
13.2.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Forecast (2019-2026)
13.2.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Forecast (2019-2026)
13.2.3 Asia-Pacific Induced Pluripotent Stem Cells (iPSCs) Market Forecast (2019-2026)
13.2.4 South America Induced Pluripotent Stem Cells (iPSCs) Market Forecast (2019-2026)
13.2.5 Middle East and Africa Induced Pluripotent Stem Cells (iPSCs) Market Forecast (2019-2026)
13.3 Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Type (2019-2026)
13.3.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Type (2019-2026)
13.3.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Share Forecast by Type (2019-2026)
13.4 Induced Pluripotent Stem Cells (iPSCs) Market Forecast by Application (2019-2026)
13.4.1 Global Induced Pluripotent Stem Cells (iPSCs) Sales Forecast by Application (2019-2026)
13.4.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Share Forecast by Application (2019-2026)
14 Sales Channel, Distributors, Traders and Dealers
14.1 Sales Channel
14.1.1 Direct Marketing
14.1.2 Indirect Marketing
14.1.3 Marketing Channel Future Trend
14.2 Market Positioning
14.2.1 Pricing Strategy
14.2.2 Brand Strategy
14.2.3 Target Client
14.3 Distributors, Traders and Dealers
15 Research Findings and Conclusion